Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02989038 · ClinicalTrials.gov registry record · NA
Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers
A NA study of Nicotine Dependence, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
- 1
- Study location
NCT02989038: Completed NA study of Nicotine Dependence, sponsored by Duke University.
NCT02989038 is a NA study of Nicotine Dependence that has completed, run by Duke University. The registered enrollment target is 182 participants, roughly in line with the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02989038, a NA study of Nicotine Dependence, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.
Primary Outcome
Smoking Effects Questionnaire ratings following administration of puffs for NNC, INC, and VLNC cigarettes
Conditions Studied
Interventions
- OTHER Very Low Nicotine Content Cigarettes
- OTHER Intermediate Nicotine Content Cigarettes
- OTHER Normal Nicotine Content Cigarettes
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2017-01 |
| Est. Completion | 2019-12-17 |
| Phase | NA |
What the finished NCT02989038 record still lists
NCT02989038 is an interventional study that assigns participants to a tested intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Very Low Nicotine Content Cigarettes is the first listed.
NCT02989038 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02989038 about?
NCT02989038 is a clinical study titled "Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers". The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.
What is the current status of trial NCT02989038?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2017-01. Estimated completion is 2019-12-17.
What conditions does trial NCT02989038 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT02989038?
The interventions under investigation include: Very Low Nicotine Content Cigarettes (OTHER), Intermediate Nicotine Content Cigarettes (OTHER), Normal Nicotine Content Cigarettes (OTHER).
Who is sponsoring clinical trial NCT02989038?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02989038 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02989038's enrollment target sits among peer trials
182 20th of 67 higher than 48 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia